This is the mail archive of the ecos-bugs@sources.redhat.com mailing list for the eCos project.


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]
Other format: [Raw text]

Well positioned equity for the future?


Big news expected  This should invoke large gains

PGCN has gained over $1.00 since Monday the 13th. 
This stock will explode the end of this week. 
Do not wait until it is too late.

New news expected this week. Expected 7 day price $9.00
                    
(SYMBOL:  PGCN)
Price: $1.88 (up from $.50 Last 4 days of trading)
Short Term Target: $27-$35
12month Target:   $50.00

************************************************
Tuesday June 14, 10:00 am ET 
BIG NEWS TODAY

HARBIN, China, June 14 Xinhua PRNewswire FirstCall
Pingchuan Pharmaceutical Inc. (OTC Bulletin Board: PGCN - News; ''PGCN'') 
announced today that PGCN signed a Regional Distribution Contract with Beijing 
Pingchuan Tianzhi Medical Technology Development Center (''TIANZHI''), a subsidiary 
wholly invested by Pingchuan Pharmaceutical Inc
*************************************************
  
Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability, pioneered
medicine products, and well-established marketing network.

Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US $120,000. Currently
it has 60 employees, 20 of them are professionals and experts on diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of
new medicines, particularly those on diabetes.

Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.

PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China, agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing through
the company's website. The marketing network of PINGCHUAN covers more than
50% districts of China and exports to US, Japan, Russia, and south-eastern
Asia.

Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30
over 400 PERCENT !!!  But We expect much more from PGCN, Sit back and watch.




IndonesiaSriLanka and the Maldives
"It'sverymoving I'll never forget this"MrBush said at a
newsconferencein the Baan Nam Khemvillagejust north of the

Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]